A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.
Investigational Treatment Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of next-day UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.
Some experts stated the demand for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Elimination
According to the social media company, the platform has removed problematic material and banned related hashtags and search suggestions. The company stated it was dedicated to keeping the service secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Operations
Research also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.
After moments of joining one community, a seller posted contact information, where most purchases occur. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, health issues or previous experience.
Product Details and Costs
Inside these groups, messages show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When questioned how long a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service stated it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Although the science behind this drug is sound, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has previously encountered patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may subject patients to possibly significant health risks”.
